Test Price
2,800 AED✅ Home Collection Available
F9 Gene Hemophilia B Next‑Generation Sequencing (NGS) Genetic Test in UAE – 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Laboratories (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a DHA-licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The F9 Gene Hemophilia B Genetic Test uses Next‑Generation Sequencing to analyse the entire F9 gene for pathogenic variants that cause factor IX deficiency (hemophilia B). Ideal for diagnostic confirmation, carrier screening, and prenatal planning, this test delivers 99.9% sensitivity and is processed in an ISO‑certified Dubai laboratory.
| Feature | Our Test (DHA‑Certified) | Closest Alternative |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene coverage | Sanger sequencing (selected exons only) |
| Turnaround Time | 3 – 4 weeks | 4 – 6 weeks |
| Diagnostic Sensitivity | 99.9% (deep intronic variants included) | ~85% |
| Pre‑ & Post‑Test Genetic Counselling | Included (DHA‑licensed counsellors) | Often not included |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that a genetic test for hemophilia B must be interpreted with a full clinical history, factor IX levels, and family pedigree. This test is a powerful tool, but never a standalone diagnosis. Always consult your hematologist before making any treatment changes.”
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA ID: 9294403
Advisory: Medication & Treatment Continuation
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Stopping factor IX concentrates or other haemostatic agents abruptly may provoke life‑threatening bleeding. This genetic test assesses your DNA; it does not replace emergency treatment plans.
Exclusion Criteria & Patient Safety
- Sample contamination: Whole blood, extracted DNA, or FTA card must be collected aseptically; clotted or hemolysed samples will be rejected.
- Incomplete clinical history: A full pedigree chart and bleeding questionnaire must be submitted; missing data delays reporting.
- Pregnancy‑related counselling: If undergoing prenatal diagnosis, an invasive procedure (amniocentesis/CVS) must be performed by a qualified obstetrician.
- ER Red Flags: If you experience sudden severe joint pain, prolonged bleeding after injury, haematuria, or intracranial pressure signs (headache, visual changes, vomiting), go to your nearest emergency department immediately regardless of test status.
Patient FAQ & Clinical Guidance
1. What is the F9 Gene Hemophilia B NGS test, and who should consider it?
The F9 gene hemophilia B NGS test is a comprehensive DNA analysis that screens the entire F9 gene for mutations causing factor IX deficiency. It is recommended for individuals with a personal or family history of prolonged bleeding, unexplained hematomas, or low factor IX activity, and for carrier detection in female relatives.
2. How should I prepare for the test, and what sample is required?
Preparation requires a genetic counselling session to draw a detailed family pedigree and provide a blood sample—whole blood, extracted DNA, or a single drop on an FTA card. No fasting is needed, and you should continue all prescribed medications; only your doctor may adjust therapy.
3. Are my genetic data and privacy protected under UAE law?
Your genetic data is strictly protected under Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Results are shared only with you and your referring physician, never with employers, insurers, or third parties without explicit consent.
UAE Regulatory & Data Privacy Adherence
This genetic test is performed in compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is processed securely within the UAE, and results are confidential.
Clinical & Logistical Metadata
| Test Name | F9 Gene Hemophilia B Next‑Generation Sequencing (NGS) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or FTA card (dried blood spot) |
| Methodology Used | Next‑Generation Sequencing (NGS) – full gene coverage |
| ICD-10-CM Code | D67 |
| LOINC Code | 51677-3 |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians